Search research articles
Contact Us
Filters
Showing results (441-450 of 471) with videos related to
Page
of 48
Sort By:
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal
|
June 8, 2021
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
Patrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal
|
November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy
Saurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Blood Cancer Journal
|
April 14, 2022
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, et al.
Mayo Clinic Proceedings
|
March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
David Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Nature Medicine
|
November 15, 2016
IAP antagonists induce anti-tumor immunity in multiple myeloma
Marta Chesi, Noweeda N Mirza, Victoria M Garbitt, et al.
Blood Cancer Journal
|
February 1, 2022
A simple additive staging system for newly diagnosed multiple myeloma
Nadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Page
of 48
Search research articles
Search
Showing results (441-450 of 471) with videos related to
Sort By:
Page
of 48
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal
|
June 8, 2021
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
Patrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal
|
November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy
Saurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Blood Cancer Journal
|
April 14, 2022
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, et al.
Mayo Clinic Proceedings
|
March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
David Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Nature Medicine
|
November 15, 2016
IAP antagonists induce anti-tumor immunity in multiple myeloma
Marta Chesi, Noweeda N Mirza, Victoria M Garbitt, et al.
Blood Cancer Journal
|
February 1, 2022
A simple additive staging system for newly diagnosed multiple myeloma
Nadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Page
of 48